Editorial
 THE ANDA GALLOP   
 Wednesday, January 16, 2019 
 In spite of several headwinds including intermittent warning letters by the US FDA even to major Indian companies, the Indian pharmaceutical companies and their subsidiaries have shown an impressive performance 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]US FDA seeks additional data from Actelion's sNDA for Opsumit to treat CTEPH
17:10  [IST]ICMRs report on pollution put on debate to consider pollution a major factor leading to the cause of death
17:00  [IST]AIVITA Biomedical receives US FDA approval to initiate phase 1B melanoma trial
16:45  [IST]Governor asks IMA to work for standardisation of medical costs at VAICON-2019 in Hyderabad
16:00  [IST]Hondros College of Nursing introduces new Medical Laboratory Technology programme
15:30  [IST]Govt bans 80 more irrational FDCs; Delhi High Court rejects pharma firms’ plea to vacate ban on diabetes drugs
more news >>
TOP NEWS
08:00  [IST]Health ministry to roll out new e-pharmacy regulations soon as draft rules being reviewed by PMO
08:00  [IST]IPC to partner with SEARN countries to share knowledge of India-specific ADR data for drug safety
08:00  [IST]TN DCA joins hands with Central TB control division to collect data from pharmacies to make India TB-free
08:00  [IST]Maharashtra govt set to roll out first phase of new triple drug therapy for lymphatic filariasis from Jan 20
08:00  [IST]Indian healthcare faces undercurrent of drain in qualified workforce with no motivation to upgrade themselves: Sameer Shariff
08:00  [IST]Indian govt’s reluctance to co-host rare disease policy event at UN upsets patient support groups
more news >>
YESTERDAY'S NEWS
18:00  [IST]LabCorp to provide enhanced laboratory services to TACHC members
17:00  [IST]TerrAscend Completes Acquisition of Grander Distribution, a US Hemp-Derived Products Company
16:10  [IST]Paras Healthcare opens 232-bed multi-super specialty hospital at Panchkula, Haryana
16:00  [IST]Inovio's dMAb PD-1 checkpoint inhibitors demonstrate higher and more prolonged expression compared to native -pembrolizumab and nivolumab sequences in preclinical studies
15:00  [IST]Abbott to buy medical device company, Cephea Valve Technologies
14:00  [IST]Sphere Fluidics, Peak Analysis and Automation collaborate to increase throughput in antibody discovery and cell line development
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspec_india_2019
anticounter_Panel_2019
Pharma_Proj
BioAsia
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |